Sawai Pharmaceutical Co., Ltd. (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Sawai Pharmaceutical Co., Ltd. (Sawai Pharmaceutical) is a pharmaceutical company, based in Japan. The company manufactures and sells pharmaceutical products. Its products include drugs for cardiovascular, gastro-intestinal, allergy and chemotherapeutic, antibiotics, blood and body fluid pharmaceutical products, vitamins and others. Sawai Pharmaceutical offers its products in the forms of tablets, capsules, granules, injections, tapes, ophthalmic and nasal solutions, and syrups. The company sells products through the brands such as, HALTHROW OD, LIMARMONE, PRAVATIN, LIPODOWN, ARTIONE, SEFTAC, ITORAT, ALLOZYM, UBIRON and METHYCOOL among others. It operates through its manufacturing units in Kyushu, Sanda, Kanto and Medisa Shinyaku. Sawai Pharmaceutical is headquartered in Osaka, Japan.

Sawai Pharmaceutical Co., Ltd. (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents  
Table of Contents  2
List of Tables  3
List of Figures  3
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013  3
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013  5
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013  6
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013  7
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013  8
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deal Details  9
Licensing Agreements  9
Acino Holding Enters Into Licensing Agreement With Sawai Pharma  9
Debt Offering  10
Sawai Pharma Completes Offering Of Convertible Bonds Due 2015 For $350 Million  10
Acquisition  11
Sawai Pharma Acquires 4.82% Stake In Kyorin Pharma  11
Sawai Pharmaceutical Co., Ltd. - Key Competitors  12
Key Employees  13
Locations And Subsidiaries  14
Head Office  14
Other Locations & Subsidiaries  14
Appendix  15
Methodology  15
About GlobalData  15
Contact Us  15
Disclaimer  15

List of Tables  
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Key Facts, 2012  1
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013  1
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013  1
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013  1
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013  4
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013  5
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013  6
Sawai Pharmaceutical Co., Ltd., Deals By Therapy Area, 2007 to YTD 2013  7
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013  8
Acino Holding Enters Into Licensing Agreement With Sawai Pharma  9
Sawai Pharma Completes Offering Of Convertible Bonds Due 2015 For $350 Million  10
Sawai Pharma Acquires 4.82% Stake In Kyorin Pharma  11
Sawai Pharmaceutical Co., Ltd., Key Competitors  12
Sawai Pharmaceutical Co., Ltd., Key Employees  13
Sawai Pharmaceutical Co., Ltd., Subsidiaries  14

List of Figures  
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013  1
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013  4
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013  5
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013  6
Sawai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013  7